Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury.
Strande, Jennifer L
Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury. [electronic resource] - Cardiovascular research Jul 2009 - 325-34 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1755-3245
10.1093/cvr/cvp122 doi
Animals
Blood Pressure--drug effects
Cardiotonic Agents--pharmacology
Coronary Circulation--drug effects
Disease Models, Animal
Dose-Response Relationship, Drug
Enzyme Inhibitors--pharmacology
Extracellular Signal-Regulated MAP Kinases--metabolism
GTP-Binding Protein alpha Subunits, Gi-Go--metabolism
Guanylate Cyclase--metabolism
Heart Rate--drug effects
KATP Channels--drug effects
Male
Myocardial Infarction--metabolism
Myocardial Reperfusion Injury--metabolism
Myocardium--metabolism
Nitric Oxide Synthase Type III--metabolism
Peptide Fragments--pharmacology
Potassium Channel Blockers--pharmacology
Rats
Rats, Sprague-Dawley
Receptor, PAR-1--metabolism
Receptors, Cytoplasmic and Nuclear--metabolism
Signal Transduction--drug effects
Soluble Guanylyl Cyclase
Time Factors
Vasodilation--drug effects
Ventricular Function, Left--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism
Parstatin: a cryptic peptide involved in cardioprotection after ischaemia and reperfusion injury. [electronic resource] - Cardiovascular research Jul 2009 - 325-34 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1755-3245
10.1093/cvr/cvp122 doi
Animals
Blood Pressure--drug effects
Cardiotonic Agents--pharmacology
Coronary Circulation--drug effects
Disease Models, Animal
Dose-Response Relationship, Drug
Enzyme Inhibitors--pharmacology
Extracellular Signal-Regulated MAP Kinases--metabolism
GTP-Binding Protein alpha Subunits, Gi-Go--metabolism
Guanylate Cyclase--metabolism
Heart Rate--drug effects
KATP Channels--drug effects
Male
Myocardial Infarction--metabolism
Myocardial Reperfusion Injury--metabolism
Myocardium--metabolism
Nitric Oxide Synthase Type III--metabolism
Peptide Fragments--pharmacology
Potassium Channel Blockers--pharmacology
Rats
Rats, Sprague-Dawley
Receptor, PAR-1--metabolism
Receptors, Cytoplasmic and Nuclear--metabolism
Signal Transduction--drug effects
Soluble Guanylyl Cyclase
Time Factors
Vasodilation--drug effects
Ventricular Function, Left--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism